Uniphar (LON:UPR) Trading Up 1.5%

Uniphar plc (LON:UPRGet Rating) shares were up 1.5% during trading on Thursday . The company traded as high as GBX 265 ($3.34) and last traded at GBX 265 ($3.34). Approximately 49,221 shares changed hands during trading, an increase of 202% from the average daily volume of 16,293 shares. The stock had previously closed at GBX 261 ($3.29).

Wall Street Analyst Weigh In

Separately, Shore Capital reissued a “buy” rating on shares of Uniphar in a report on Wednesday, March 22nd.

Uniphar Price Performance

The business has a 50 day moving average price of GBX 268.31 and a two-hundred day moving average price of GBX 282.26. The stock has a market cap of £723.50 million, a PE ratio of 1,766.67 and a beta of 0.76. The company has a debt-to-equity ratio of 97.55, a quick ratio of 0.60 and a current ratio of 0.99.

Uniphar Increases Dividend

The firm also recently announced a dividend, which will be paid on Tuesday, May 16th. Stockholders of record on Thursday, April 20th will be paid a €0.01 ($0.01) dividend. This represents a dividend yield of 0.33%. The ex-dividend date of this dividend is Thursday, April 20th. This is an increase from Uniphar’s previous dividend of $0.01. Uniphar’s payout ratio is presently 666.67%.

Uniphar Company Profile

(Get Rating)

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers.

Read More

Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.